

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | drug transmembrane transport (GO:0006855) | 7.21566012 |
| 2 | urate metabolic process (GO:0046415) | 6.57592089 |
| 3 | aminoglycoside antibiotic metabolic process (GO:0030647) | 6.36619578 |
| 4 | lysine metabolic process (GO:0006553) | 6.32774363 |
| 5 | lysine catabolic process (GO:0006554) | 6.32774363 |
| 6 | phosphate ion transport (GO:0006817) | 6.00906126 |
| 7 | organic cation transport (GO:0015695) | 5.80059597 |
| 8 | drug transport (GO:0015893) | 5.78913190 |
| 9 | response to mercury ion (GO:0046689) | 5.49608599 |
| 10 | tricarboxylic acid metabolic process (GO:0072350) | 5.38677543 |
| 11 | excretion (GO:0007588) | 5.25716648 |
| 12 | quaternary ammonium group transport (GO:0015697) | 4.89546854 |
| 13 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.76888158 |
| 14 | protein carboxylation (GO:0018214) | 4.76888158 |
| 15 | phosphate ion transmembrane transport (GO:0035435) | 4.69872206 |
| 16 | metanephric tubule development (GO:0072170) | 4.62743358 |
| 17 | metanephric nephron tubule development (GO:0072234) | 4.62743358 |
| 18 | Golgi transport vesicle coating (GO:0048200) | 4.62124879 |
| 19 | COPI coating of Golgi vesicle (GO:0048205) | 4.62124879 |
| 20 | intestinal cholesterol absorption (GO:0030299) | 4.52574784 |
| 21 | glyoxylate metabolic process (GO:0046487) | 4.34103677 |
| 22 | metanephric nephron epithelium development (GO:0072243) | 4.26904252 |
| 23 | aspartate family amino acid catabolic process (GO:0009068) | 4.24180287 |
| 24 | short-chain fatty acid metabolic process (GO:0046459) | 4.16923181 |
| 25 | behavioral response to nicotine (GO:0035095) | 4.15727380 |
| 26 | drug catabolic process (GO:0042737) | 4.13555603 |
| 27 | metanephric epithelium development (GO:0072207) | 4.11133041 |
| 28 | cellular response to vitamin D (GO:0071305) | 4.05307273 |
| 29 | cysteine metabolic process (GO:0006534) | 4.00790563 |
| 30 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.99713436 |
| 31 | valine metabolic process (GO:0006573) | 3.95631868 |
| 32 | branched-chain amino acid metabolic process (GO:0009081) | 3.93676446 |
| 33 | carnitine transport (GO:0015879) | 3.91777143 |
| 34 | amino-acid betaine transport (GO:0015838) | 3.91777143 |
| 35 | sulfate transmembrane transport (GO:1902358) | 3.88117663 |
| 36 | intestinal absorption (GO:0050892) | 3.85978081 |
| 37 | * renal absorption (GO:0070293) | 3.84331634 |
| 38 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.81503785 |
| 39 | 2-oxoglutarate metabolic process (GO:0006103) | 3.80008464 |
| 40 | peptide catabolic process (GO:0043171) | 3.78763715 |
| 41 | protein retention in ER lumen (GO:0006621) | 3.78406725 |
| 42 | fatty acid beta-oxidation (GO:0006635) | 3.76647683 |
| 43 | negative regulation of fibrinolysis (GO:0051918) | 3.76391709 |
| 44 | * nephron tubule morphogenesis (GO:0072078) | 3.75942475 |
| 45 | * nephron epithelium morphogenesis (GO:0072088) | 3.75942475 |
| 46 | L-phenylalanine metabolic process (GO:0006558) | 3.73961930 |
| 47 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.73961930 |
| 48 | toxin transport (GO:1901998) | 3.72184942 |
| 49 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.70715817 |
| 50 | L-phenylalanine catabolic process (GO:0006559) | 3.70715817 |
| 51 | exogenous drug catabolic process (GO:0042738) | 3.70523141 |
| 52 | regulation of fibrinolysis (GO:0051917) | 3.69698451 |
| 53 | nephron tubule development (GO:0072080) | 3.64895514 |
| 54 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.62323605 |
| 55 | NADH metabolic process (GO:0006734) | 3.62298187 |
| 56 | regulation of plasminogen activation (GO:0010755) | 3.60257027 |
| 57 | proline metabolic process (GO:0006560) | 3.59091929 |
| 58 | high-density lipoprotein particle remodeling (GO:0034375) | 3.56438176 |
| 59 | positive regulation of protein kinase C signaling (GO:0090037) | 3.55548053 |
| 60 | sulfate transport (GO:0008272) | 3.52548866 |
| 61 | L-fucose catabolic process (GO:0042355) | 3.46494902 |
| 62 | fucose catabolic process (GO:0019317) | 3.46494902 |
| 63 | L-fucose metabolic process (GO:0042354) | 3.46494902 |
| 64 | 4-hydroxyproline metabolic process (GO:0019471) | 3.46020870 |
| 65 | fatty acid oxidation (GO:0019395) | 3.41494250 |
| 66 | response to parathyroid hormone (GO:0071107) | 3.40931702 |
| 67 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.40720088 |
| 68 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.40720088 |
| 69 | vitamin D metabolic process (GO:0042359) | 3.40441212 |
| 70 | tricarboxylic acid cycle (GO:0006099) | 3.38326213 |
| 71 | membrane repolarization during action potential (GO:0086011) | 3.38100093 |
| 72 | peristalsis (GO:0030432) | 3.35073738 |
| 73 | phosphate ion homeostasis (GO:0055062) | 3.34392038 |
| 74 | trivalent inorganic anion homeostasis (GO:0072506) | 3.34392038 |
| 75 | homocysteine metabolic process (GO:0050667) | 3.32973922 |
| 76 | lipid oxidation (GO:0034440) | 3.32505275 |
| 77 | glycoside metabolic process (GO:0016137) | 3.32434034 |
| 78 | lung epithelium development (GO:0060428) | 3.30695734 |
| 79 | fucosylation (GO:0036065) | 3.30226687 |
| 80 | cellular response to vitamin (GO:0071295) | 3.28447663 |
| 81 | branched-chain amino acid catabolic process (GO:0009083) | 3.27637333 |
| 82 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.27607184 |
| 83 | renal tubule development (GO:0061326) | 3.27487079 |
| 84 | cellular ketone body metabolic process (GO:0046950) | 3.23969436 |
| 85 | cellular response to ATP (GO:0071318) | 3.23170339 |
| 86 | reverse cholesterol transport (GO:0043691) | 3.21692574 |
| 87 | cellular modified amino acid catabolic process (GO:0042219) | 3.21518193 |
| 88 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.18915687 |
| 89 | transepithelial transport (GO:0070633) | 3.16589582 |
| 90 | collecting duct development (GO:0072044) | 3.16495085 |
| 91 | plasma lipoprotein particle assembly (GO:0034377) | 3.16099388 |
| 92 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.14345889 |
| 93 | polyol transport (GO:0015791) | 3.12220394 |
| 94 | protein-lipid complex remodeling (GO:0034368) | 3.12148971 |
| 95 | macromolecular complex remodeling (GO:0034367) | 3.12148971 |
| 96 | plasma lipoprotein particle remodeling (GO:0034369) | 3.12148971 |
| 97 | aromatic amino acid family catabolic process (GO:0009074) | 3.08661740 |
| 98 | endocardial cushion development (GO:0003197) | 3.08242026 |
| 99 | regulation of cholesterol homeostasis (GO:2000188) | 3.04989851 |
| 100 | amino-acid betaine metabolic process (GO:0006577) | 3.03522819 |
| 101 | response to vitamin A (GO:0033189) | 3.03442030 |
| 102 | carnitine metabolic process (GO:0009437) | 3.02868244 |
| 103 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.02636764 |
| 104 | surfactant homeostasis (GO:0043129) | 3.02086035 |
| 105 | fatty acid catabolic process (GO:0009062) | 3.02014175 |
| 106 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.99002683 |
| 107 | meiotic chromosome segregation (GO:0045132) | 2.96770069 |
| 108 | glutathione biosynthetic process (GO:0006750) | 2.96145740 |
| 109 | nephron epithelium development (GO:0072009) | 2.92087558 |
| 110 | positive regulation of fatty acid oxidation (GO:0046321) | 2.90431899 |
| 111 | plasma lipoprotein particle organization (GO:0071827) | 2.89905115 |
| 112 | beta-amyloid metabolic process (GO:0050435) | 2.89614758 |
| 113 | endocrine pancreas development (GO:0031018) | 2.86884215 |
| 114 | mannosylation (GO:0097502) | 2.86350146 |
| 115 | ketone body metabolic process (GO:1902224) | 2.82059850 |
| 116 | regulation of hexokinase activity (GO:1903299) | 2.81954654 |
| 117 | regulation of glucokinase activity (GO:0033131) | 2.81954654 |
| 118 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.81785425 |
| 119 | sulfur compound transport (GO:0072348) | 2.81531251 |
| 120 | peptide hormone processing (GO:0016486) | 2.81314086 |
| 121 | DNA damage induced protein phosphorylation (GO:0006975) | 2.81121054 |
| 122 | negative regulation of sodium ion transport (GO:0010766) | 2.79520460 |
| 123 | peptidyl-glutamic acid modification (GO:0018200) | 2.79178350 |
| 124 | oxaloacetate metabolic process (GO:0006107) | 2.76473109 |
| 125 | toxin metabolic process (GO:0009404) | 2.75859474 |
| 126 | GDP-mannose metabolic process (GO:0019673) | 2.75700110 |
| 127 | modified amino acid transport (GO:0072337) | 2.73557702 |
| 128 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.72751294 |
| 129 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.71951592 |
| 130 | succinate metabolic process (GO:0006105) | 2.71569567 |
| 131 | fructose metabolic process (GO:0006000) | 2.71497349 |
| 132 | arginine metabolic process (GO:0006525) | 2.71465023 |
| 133 | monocarboxylic acid catabolic process (GO:0072329) | 2.70452688 |
| 134 | acetyl-CoA metabolic process (GO:0006084) | 2.68692674 |
| 135 | low-density lipoprotein particle remodeling (GO:0034374) | 2.67462407 |
| 136 | peptide biosynthetic process (GO:0043043) | 2.67335502 |
| 137 | regulation of G0 to G1 transition (GO:0070316) | 2.67308858 |
| 138 | amino acid transmembrane transport (GO:0003333) | 2.66415746 |
| 139 | COPII vesicle coating (GO:0048208) | 2.66407778 |
| 140 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.66016948 |
| 141 | carnitine transmembrane transport (GO:1902603) | 2.65500721 |
| 142 | DNA strand renaturation (GO:0000733) | 2.63693907 |
| 143 | cholesterol efflux (GO:0033344) | 2.61832471 |
| 144 | cellular response to nutrient (GO:0031670) | 2.61508994 |
| 145 | biotin metabolic process (GO:0006768) | 2.58713861 |
| 146 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.57041804 |
| 147 | detection of light stimulus involved in visual perception (GO:0050908) | 2.57041804 |
| 148 | regulation of hippo signaling (GO:0035330) | 2.55562553 |
| 149 | glycerophospholipid catabolic process (GO:0046475) | 2.55492926 |
| 150 | protein-lipid complex subunit organization (GO:0071825) | 2.55472101 |
| 151 | actin filament depolymerization (GO:0030042) | 2.55350458 |
| 152 | cellular anion homeostasis (GO:0030002) | 2.55312221 |
| 153 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.54317760 |
| 154 | positive regulation of glycolytic process (GO:0045821) | 2.53828533 |
| 155 | tryptophan catabolic process (GO:0006569) | 2.53823241 |
| 156 | indole-containing compound catabolic process (GO:0042436) | 2.53823241 |
| 157 | indolalkylamine catabolic process (GO:0046218) | 2.53823241 |
| 158 | * renal tubule morphogenesis (GO:0061333) | 2.53737620 |
| 159 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.51964120 |
| 160 | tryptophan metabolic process (GO:0006568) | 2.51864793 |
| 161 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.50387782 |
| 162 | protein-lipid complex assembly (GO:0065005) | 2.50061719 |
| 163 | urogenital system development (GO:0001655) | 2.47019905 |
| 164 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.44672671 |
| 165 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.43180684 |
| 166 | proline biosynthetic process (GO:0006561) | 2.42260256 |
| 167 | fucose metabolic process (GO:0006004) | 2.41057668 |
| 168 | negative regulation of cholesterol transport (GO:0032375) | 2.40051791 |
| 169 | negative regulation of sterol transport (GO:0032372) | 2.40051791 |
| 170 | response to pheromone (GO:0019236) | 2.38296096 |
| 171 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.37423503 |
| 172 | regulation of apoptotic cell clearance (GO:2000425) | 2.37261822 |
| 173 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.36641570 |
| 174 | phasic smooth muscle contraction (GO:0014821) | 2.36618277 |
| 175 | positive regulation of hormone metabolic process (GO:0032352) | 2.35238261 |
| 176 | basic amino acid transport (GO:0015802) | 2.34695764 |
| 177 | response to misfolded protein (GO:0051788) | 2.33691790 |
| 178 | regulation of cholesterol metabolic process (GO:0090181) | 2.32468641 |
| 179 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 2.28110591 |
| 180 | vitamin transmembrane transport (GO:0035461) | 2.26265215 |
| 181 | lymphangiogenesis (GO:0001946) | 2.26228115 |
| 182 | bicarbonate transport (GO:0015701) | 2.25967781 |
| 183 | DNA replication checkpoint (GO:0000076) | 2.25956236 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.80383932 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.57213730 |
| 3 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.40035467 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.36106163 |
| 5 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.09870098 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.03515741 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.97210315 |
| 8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.82901078 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.81700065 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.59425392 |
| 11 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.46324975 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.41065614 |
| 13 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.36393983 |
| 14 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.34895616 |
| 15 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.25019711 |
| 16 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.22076476 |
| 17 | * E2F1_20622854_ChIP-Seq_HELA_Human | 2.18379482 |
| 18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.04570493 |
| 19 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.97410589 |
| 20 | ERA_21632823_ChIP-Seq_H3396_Human | 1.91016483 |
| 21 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.90449061 |
| 22 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.83798369 |
| 23 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.83190881 |
| 24 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.83190881 |
| 25 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.82608702 |
| 26 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.79096562 |
| 27 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.78048733 |
| 28 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.75985421 |
| 29 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.73700836 |
| 30 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.73652607 |
| 31 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.70946766 |
| 32 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.70373551 |
| 33 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.69904229 |
| 34 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.69490323 |
| 35 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.68269340 |
| 36 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.68076091 |
| 37 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.62767107 |
| 38 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.59150374 |
| 39 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.58465577 |
| 40 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.57520192 |
| 41 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.56691015 |
| 42 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.55689849 |
| 43 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.55635272 |
| 44 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.55169814 |
| 45 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.53993001 |
| 46 | * RAC3_21632823_ChIP-Seq_H3396_Human | 1.53445628 |
| 47 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.53229837 |
| 48 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.52097335 |
| 49 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.51588738 |
| 50 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.50581403 |
| 51 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.50407130 |
| 52 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 1.47241933 |
| 53 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.46127810 |
| 54 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.44367740 |
| 55 | GATA1_22025678_ChIP-Seq_K562_Human | 1.43901738 |
| 56 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.43737992 |
| 57 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.42978173 |
| 58 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.42357970 |
| 59 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.41910119 |
| 60 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.40276614 |
| 61 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.40013885 |
| 62 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.37271190 |
| 63 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 1.36994052 |
| 64 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.36222319 |
| 65 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.35606941 |
| 66 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.31438173 |
| 67 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.31428650 |
| 68 | * TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.31360678 |
| 69 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.30678907 |
| 70 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.30380396 |
| 71 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.30008698 |
| 72 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.28250958 |
| 73 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.28035089 |
| 74 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.27231104 |
| 75 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.25678860 |
| 76 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.24521997 |
| 77 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.23519407 |
| 78 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.23460502 |
| 79 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.23176972 |
| 80 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.22907002 |
| 81 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.22866038 |
| 82 | * NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 1.22245947 |
| 83 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.21467479 |
| 84 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.21127374 |
| 85 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.20440516 |
| 86 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20079464 |
| 87 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.19293326 |
| 88 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.19222733 |
| 89 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.19218119 |
| 90 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18563820 |
| 91 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.18110835 |
| 92 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.17326777 |
| 93 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.17209990 |
| 94 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.15888841 |
| 95 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.15810596 |
| 96 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.15739307 |
| 97 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.15639985 |
| 98 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.15389604 |
| 99 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.15199097 |
| 100 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.14697830 |
| 101 | ATF3_27146783_Chip-Seq_COLON_Human | 1.13644986 |
| 102 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.13148816 |
| 103 | P300_27268052_Chip-Seq_Bcells_Human | 1.11543053 |
| 104 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.11348968 |
| 105 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.11154271 |
| 106 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.11077344 |
| 107 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.10967831 |
| 108 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.10944448 |
| 109 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.10483785 |
| 110 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.09931994 |
| 111 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.09756816 |
| 112 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.09138484 |
| 113 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.09027084 |
| 114 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.08716746 |
| 115 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.08307334 |
| 116 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.08258745 |
| 117 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08231663 |
| 118 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 1.08012687 |
| 119 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.07014040 |
| 120 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.06522701 |
| 121 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.06139537 |
| 122 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.06124421 |
| 123 | KDM2B_26808549_Chip-Seq_K562_Human | 1.06058831 |
| 124 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05768356 |
| 125 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04805380 |
| 126 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.03830758 |
| 127 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01088197 |
| 128 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.01013826 |
| 129 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.00839794 |
| 130 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00331069 |
| 131 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.00309376 |
| 132 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.99051485 |
| 133 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.99016917 |
| 134 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.98948890 |
| 135 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.97560426 |
| 136 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.97053424 |
| 137 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.96901866 |
| 138 | VDR_22108803_ChIP-Seq_LS180_Human | 0.96802030 |
| 139 | NCOR_22424771_ChIP-Seq_293T_Human | 0.96013426 |
| 140 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.95724838 |
| 141 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.95656362 |
| 142 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.94437307 |
| 143 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.94241398 |
| 144 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.93913812 |
| 145 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.93879905 |
| 146 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.93000320 |
| 147 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.92983539 |
| 148 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.92912342 |
| 149 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.92879936 |
| 150 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.92319990 |
| 151 | P68_20966046_ChIP-Seq_HELA_Human | 0.92266527 |
| 152 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.90599726 |
| 153 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.89597960 |
| 154 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.89219668 |
| 155 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.87712853 |
| 156 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.87149334 |
| 157 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.86709994 |
| 158 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86152155 |
| 159 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.83610245 |
| 160 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.82912018 |
| 161 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.81363837 |
| 162 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.80540233 |
| 163 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.80398967 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0004043_abnormal_pH_regulation | 5.64032788 |
| 2 | MP0003195_calcinosis | 5.29108534 |
| 3 | MP0005360_urolithiasis | 4.42196399 |
| 4 | MP0009643_abnormal_urine_homeostasis | 3.48794659 |
| 5 | * MP0001765_abnormal_ion_homeostasis | 3.40596880 |
| 6 | MP0004019_abnormal_vitamin_homeostasis | 3.35120142 |
| 7 | MP0001756_abnormal_urination | 3.33377250 |
| 8 | MP0005332_abnormal_amino_acid | 3.28841216 |
| 9 | MP0003136_yellow_coat_color | 3.14975914 |
| 10 | MP0002139_abnormal_hepatobiliary_system | 3.08199258 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 2.94186232 |
| 12 | MP0003283_abnormal_digestive_organ | 2.93317337 |
| 13 | MP0002837_dystrophic_cardiac_calcinosis | 2.67584177 |
| 14 | MP0008961_abnormal_basal_metabolism | 2.57024083 |
| 15 | * MP0005636_abnormal_mineral_homeostasis | 2.51095457 |
| 16 | MP0006292_abnormal_olfactory_placode | 2.37109617 |
| 17 | MP0005377_hearing/vestibular/ear_phenot | 2.29439885 |
| 18 | MP0003878_abnormal_ear_physiology | 2.29439885 |
| 19 | MP0010329_abnormal_lipoprotein_level | 2.24800473 |
| 20 | MP0003252_abnormal_bile_duct | 2.21174737 |
| 21 | * MP0002136_abnormal_kidney_physiology | 2.16723020 |
| 22 | MP0000013_abnormal_adipose_tissue | 2.15942368 |
| 23 | MP0005171_absent_coat_pigmentation | 2.12343483 |
| 24 | MP0008438_abnormal_cutaneous_collagen | 1.92598774 |
| 25 | MP0005365_abnormal_bile_salt | 1.89333853 |
| 26 | MP0000566_synostosis | 1.86416080 |
| 27 | MP0000678_abnormal_parathyroid_gland | 1.82910640 |
| 28 | MP0002938_white_spotting | 1.80119387 |
| 29 | MP0009780_abnormal_chondrocyte_physiolo | 1.79492904 |
| 30 | MP0003300_gastrointestinal_ulcer | 1.79410750 |
| 31 | MP0005174_abnormal_tail_pigmentation | 1.74864173 |
| 32 | MP0005551_abnormal_eye_electrophysiolog | 1.73773848 |
| 33 | MP0003123_paternal_imprinting | 1.73470886 |
| 34 | MP0004264_abnormal_extraembryonic_tissu | 1.72379063 |
| 35 | MP0005220_abnormal_exocrine_pancreas | 1.63493229 |
| 36 | MP0004133_heterotaxia | 1.63432531 |
| 37 | MP0001944_abnormal_pancreas_morphology | 1.61989480 |
| 38 | MP0001958_emphysema | 1.59834959 |
| 39 | MP0002896_abnormal_bone_mineralization | 1.59514114 |
| 40 | MP0002909_abnormal_adrenal_gland | 1.58882236 |
| 41 | MP0005084_abnormal_gallbladder_morpholo | 1.57717669 |
| 42 | MP0000003_abnormal_adipose_tissue | 1.54585521 |
| 43 | MP0000538_abnormal_urinary_bladder | 1.51233471 |
| 44 | MP0005058_abnormal_lysosome_morphology | 1.49818975 |
| 45 | MP0002928_abnormal_bile_duct | 1.49771053 |
| 46 | MP0005257_abnormal_intraocular_pressure | 1.42675153 |
| 47 | MP0008875_abnormal_xenobiotic_pharmacok | 1.42600106 |
| 48 | MP0002160_abnormal_reproductive_system | 1.41805168 |
| 49 | MP0010386_abnormal_urinary_bladder | 1.39458186 |
| 50 | MP0002877_abnormal_melanocyte_morpholog | 1.36491867 |
| 51 | MP0010368_abnormal_lymphatic_system | 1.35464497 |
| 52 | MP0004885_abnormal_endolymph | 1.34990081 |
| 53 | MP0005085_abnormal_gallbladder_physiolo | 1.34548834 |
| 54 | MP0001188_hyperpigmentation | 1.32638303 |
| 55 | MP0004084_abnormal_cardiac_muscle | 1.31461623 |
| 56 | MP0005409_darkened_coat_color | 1.30217173 |
| 57 | * MP0000230_abnormal_systemic_arterial | 1.29179885 |
| 58 | MP0002168_other_aberrant_phenotype | 1.28940450 |
| 59 | MP0005670_abnormal_white_adipose | 1.27458549 |
| 60 | MP0004272_abnormal_basement_membrane | 1.27389549 |
| 61 | MP0001502_abnormal_circadian_rhythm | 1.26762256 |
| 62 | MP0005375_adipose_tissue_phenotype | 1.26106008 |
| 63 | MP0010234_abnormal_vibrissa_follicle | 1.22205126 |
| 64 | MP0002078_abnormal_glucose_homeostasis | 1.17836668 |
| 65 | MP0001968_abnormal_touch/_nociception | 1.17432090 |
| 66 | MP0003950_abnormal_plasma_membrane | 1.14532815 |
| 67 | MP0002249_abnormal_larynx_morphology | 1.13936716 |
| 68 | MP0005666_abnormal_adipose_tissue | 1.13259480 |
| 69 | MP0001666_abnormal_nutrient_absorption | 1.12775392 |
| 70 | MP0005410_abnormal_fertilization | 1.10063600 |
| 71 | MP0002234_abnormal_pharynx_morphology | 1.09374555 |
| 72 | MP0001348_abnormal_lacrimal_gland | 1.08155699 |
| 73 | MP0000751_myopathy | 1.07925479 |
| 74 | MP0001986_abnormal_taste_sensitivity | 1.06261545 |
| 75 | MP0003172_abnormal_lysosome_physiology | 1.04430071 |
| 76 | MP0002693_abnormal_pancreas_physiology | 1.03534844 |
| 77 | MP0003119_abnormal_digestive_system | 1.01910005 |
| 78 | MP0003959_abnormal_lean_body | 1.01807251 |
| 79 | MP0006036_abnormal_mitochondrial_physio | 1.01350425 |
| 80 | MP0004233_abnormal_muscle_weight | 0.97834969 |
| 81 | MP0006054_spinal_hemorrhage | 0.97785426 |
| 82 | MP0004215_abnormal_myocardial_fiber | 0.97567038 |
| 83 | MP0003937_abnormal_limbs/digits/tail_de | 0.97486798 |
| 84 | MP0001270_distended_abdomen | 0.94603619 |
| 85 | MP0002135_abnormal_kidney_morphology | 0.94327100 |
| 86 | MP0003705_abnormal_hypodermis_morpholog | 0.93425131 |
| 87 | MP0005330_cardiomyopathy | 0.91751011 |
| 88 | MP0004036_abnormal_muscle_relaxation | 0.91013859 |
| 89 | MP0005503_abnormal_tendon_morphology | 0.90993402 |
| 90 | MP0000534_abnormal_ureter_morphology | 0.90430551 |
| 91 | MP0001661_extended_life_span | 0.89651481 |
| 92 | MP0002972_abnormal_cardiac_muscle | 0.87352753 |
| 93 | MP0009046_muscle_twitch | 0.86398906 |
| 94 | MP0008872_abnormal_physiological_respon | 0.85120787 |
| 95 | MP0005319_abnormal_enzyme/_coenzyme | 0.84355213 |
| 96 | MP0003646_muscle_fatigue | 0.83333979 |
| 97 | MP0008995_early_reproductive_senescence | 0.83227436 |
| 98 | MP0003953_abnormal_hormone_level | 0.83195943 |
| 99 | MP0005448_abnormal_energy_balance | 0.82367435 |
| 100 | MP0004147_increased_porphyrin_level | 0.81976245 |
| 101 | MP0005535_abnormal_body_temperature | 0.81634750 |
| 102 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.79797656 |
| 103 | MP0003183_abnormal_peptide_metabolism | 0.79639066 |
| 104 | MP0008775_abnormal_heart_ventricle | 0.78137926 |
| 105 | MP0009840_abnormal_foam_cell | 0.77495268 |
| 106 | MP0002118_abnormal_lipid_homeostasis | 0.77441735 |
| 107 | MP0002089_abnormal_postnatal_growth/wei | 0.77128656 |
| 108 | MP0000639_abnormal_adrenal_gland | 0.76032459 |
| 109 | MP0000462_abnormal_digestive_system | 0.73315377 |
| 110 | MP0000747_muscle_weakness | 0.73256348 |
| 111 | MP0003879_abnormal_hair_cell | 0.72715312 |
| 112 | MP0005083_abnormal_biliary_tract | 0.71816487 |
| 113 | MP0005620_abnormal_muscle_contractility | 0.71604022 |
| 114 | MP0003718_maternal_effect | 0.71039523 |
| 115 | MP0002282_abnormal_trachea_morphology | 0.70503568 |
| 116 | MP0001324_abnormal_eye_pigmentation | 0.70161423 |
| 117 | MP0005195_abnormal_posterior_eye | 0.69511402 |
| 118 | MP0005167_abnormal_blood-brain_barrier | 0.69248299 |
| 119 | MP0003045_fibrosis | 0.68865005 |
| 120 | MP0005646_abnormal_pituitary_gland | 0.68803701 |
| 121 | MP0004145_abnormal_muscle_electrophysio | 0.68085948 |
| 122 | MP0002557_abnormal_social/conspecific_i | 0.67760482 |
| 123 | MP0002876_abnormal_thyroid_physiology | 0.66914912 |
| 124 | MP0003122_maternal_imprinting | 0.66638564 |
| 125 | MP0000371_diluted_coat_color | 0.66161308 |
| 126 | MP0005408_hypopigmentation | 0.65700472 |
| 127 | MP0010030_abnormal_orbit_morphology | 0.65506090 |
| 128 | MP0005389_reproductive_system_phenotype | 0.64857047 |
| 129 | MP0003942_abnormal_urinary_system | 0.64769039 |
| 130 | MP0003121_genomic_imprinting | 0.64507557 |
| 131 | MP0002098_abnormal_vibrissa_morphology | 0.64343739 |
| 132 | MP0002269_muscular_atrophy | 0.64220411 |
| 133 | MP0000609_abnormal_liver_physiology | 0.62716604 |
| 134 | * MP0009642_abnormal_blood_homeostasis | 0.62466295 |
| 135 | MP0001293_anophthalmia | 0.62299518 |
| 136 | MP0000163_abnormal_cartilage_morphology | 0.61992510 |
| 137 | MP0009672_abnormal_birth_weight | 0.61497995 |
| 138 | MP0003315_abnormal_perineum_morphology | 0.61194626 |
| 139 | MP0004142_abnormal_muscle_tone | 0.61018866 |
| 140 | MP0003943_abnormal_hepatobiliary_system | 0.60507174 |
| 141 | MP0003786_premature_aging | 0.60218505 |
| 142 | MP0003566_abnormal_cell_adhesion | 0.59082160 |
| 143 | MP0009384_cardiac_valve_regurgitation | 0.57127653 |
| 144 | MP0001664_abnormal_digestion | 0.56332296 |
| 145 | MP0002108_abnormal_muscle_morphology | 0.54956332 |
| 146 | MP0003137_abnormal_impulse_conducting | 0.52851156 |
| 147 | MP0003795_abnormal_bone_structure | 0.52125084 |
| 148 | MP0000537_abnormal_urethra_morphology | 0.50877086 |
| 149 | MP0005385_cardiovascular_system_phenoty | 0.50398755 |
| 150 | MP0001544_abnormal_cardiovascular_syste | 0.50398755 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased circulating renin level (HP:0000848) | 7.81653298 |
| 2 | Hypokalemic alkalosis (HP:0001949) | 7.53561680 |
| 3 | Metabolic alkalosis (HP:0200114) | 7.16254354 |
| 4 | Hyperactive renin-angiotensin system (HP:0000841) | 7.00782999 |
| 5 | Hypomagnesemia (HP:0002917) | 6.40527964 |
| 6 | Polyuria (HP:0000103) | 6.30567260 |
| 7 | Gout (HP:0001997) | 6.07405567 |
| 8 | * Abnormality of chloride homeostasis (HP:0011422) | 5.90809783 |
| 9 | Abnormal urine output (HP:0012590) | 5.89936778 |
| 10 | Abnormality of magnesium homeostasis (HP:0004921) | 5.63999415 |
| 11 | Abnormality of renal excretion (HP:0011036) | 5.56656175 |
| 12 | Abnormality of renin-angiotensin system (HP:0000847) | 5.35274735 |
| 13 | Abnormal drinking behavior (HP:0030082) | 5.17900678 |
| 14 | Polydipsia (HP:0001959) | 5.17900678 |
| 15 | Hyperaldosteronism (HP:0000859) | 5.00586842 |
| 16 | Tetany (HP:0001281) | 4.95110207 |
| 17 | Renal salt wasting (HP:0000127) | 4.78732565 |
| 18 | Alkalosis (HP:0001948) | 4.72696972 |
| 19 | Hypokalemia (HP:0002900) | 4.58185602 |
| 20 | Ketoacidosis (HP:0001993) | 4.39109298 |
| 21 | Increased purine levels (HP:0004368) | 4.04130476 |
| 22 | Hyperuricemia (HP:0002149) | 4.04130476 |
| 23 | Proximal tubulopathy (HP:0000114) | 3.93456784 |
| 24 | Hypercalciuria (HP:0002150) | 3.76254524 |
| 25 | Prolonged partial thromboplastin time (HP:0003645) | 3.68271538 |
| 26 | Abnormality of purine metabolism (HP:0004352) | 3.50848044 |
| 27 | Deep venous thrombosis (HP:0002625) | 3.46586256 |
| 28 | * Abnormality of potassium homeostasis (HP:0011042) | 3.45314695 |
| 29 | Generalized aminoaciduria (HP:0002909) | 3.42233236 |
| 30 | Congenital stationary night blindness (HP:0007642) | 3.27891609 |
| 31 | Hypoglycemic coma (HP:0001325) | 3.25956613 |
| 32 | Hyperglycinuria (HP:0003108) | 3.25905853 |
| 33 | Ketosis (HP:0001946) | 3.25230600 |
| 34 | Hemorrhage of the eye (HP:0011885) | 3.25072940 |
| 35 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.11052135 |
| 36 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.04950168 |
| 37 | Decreased circulating renin level (HP:0003351) | 2.84295960 |
| 38 | Testicular atrophy (HP:0000029) | 2.83976315 |
| 39 | Adrenal overactivity (HP:0002717) | 2.83579547 |
| 40 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.83311985 |
| 41 | Glycosuria (HP:0003076) | 2.80644368 |
| 42 | Abnormality of urine glucose concentration (HP:0011016) | 2.80644368 |
| 43 | Late onset (HP:0003584) | 2.74050808 |
| 44 | Cystic liver disease (HP:0006706) | 2.72730376 |
| 45 | Metaphyseal cupping (HP:0003021) | 2.71437153 |
| 46 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.70246433 |
| 47 | Pendular nystagmus (HP:0012043) | 2.69159492 |
| 48 | Hypophosphatemic rickets (HP:0004912) | 2.63823097 |
| 49 | Nephrocalcinosis (HP:0000121) | 2.62636724 |
| 50 | Hypoglycemic seizures (HP:0002173) | 2.61999002 |
| 51 | Mesangial abnormality (HP:0001966) | 2.61718568 |
| 52 | Hyperphosphaturia (HP:0003109) | 2.58853687 |
| 53 | Symptomatic seizures (HP:0011145) | 2.57577016 |
| 54 | Abnormality of sodium homeostasis (HP:0010931) | 2.57224007 |
| 55 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.56883321 |
| 56 | Patellar aplasia (HP:0006443) | 2.56164773 |
| 57 | Joint hemorrhage (HP:0005261) | 2.55242292 |
| 58 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.54106125 |
| 59 | Abnormality of glycine metabolism (HP:0010895) | 2.53078604 |
| 60 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.53078604 |
| 61 | Hyponatremia (HP:0002902) | 2.52129721 |
| 62 | Renal tubular acidosis (HP:0001947) | 2.51865222 |
| 63 | Attenuation of retinal blood vessels (HP:0007843) | 2.50601212 |
| 64 | Abnormal urine phosphate concentration (HP:0012599) | 2.48008891 |
| 65 | Rib fusion (HP:0000902) | 2.47583618 |
| 66 | Abnormality of the nasal septum (HP:0000419) | 2.44186796 |
| 67 | Ileus (HP:0002595) | 2.44148886 |
| 68 | Abnormality of the vitreous humor (HP:0004327) | 2.41744580 |
| 69 | Hypophosphatemia (HP:0002148) | 2.41661247 |
| 70 | Delayed epiphyseal ossification (HP:0002663) | 2.40586851 |
| 71 | Xanthomatosis (HP:0000991) | 2.38309799 |
| 72 | Birth length less than 3rd percentile (HP:0003561) | 2.38069309 |
| 73 | Abnormality of the renal cortex (HP:0011035) | 2.34118128 |
| 74 | Type II lissencephaly (HP:0007260) | 2.29255994 |
| 75 | Hypotension (HP:0002615) | 2.29140546 |
| 76 | Abnormality of nucleobase metabolism (HP:0010932) | 2.27269006 |
| 77 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.27002932 |
| 78 | Nephrolithiasis (HP:0000787) | 2.26481838 |
| 79 | Severe muscular hypotonia (HP:0006829) | 2.23942350 |
| 80 | Abnormality of midbrain morphology (HP:0002418) | 2.22806245 |
| 81 | Molar tooth sign on MRI (HP:0002419) | 2.22806245 |
| 82 | Pancreatic cysts (HP:0001737) | 2.21410904 |
| 83 | Hydroxyprolinuria (HP:0003080) | 2.21084447 |
| 84 | Abnormality of proline metabolism (HP:0010907) | 2.21084447 |
| 85 | Chondrocalcinosis (HP:0000934) | 2.18442255 |
| 86 | Abnormal pancreas size (HP:0012094) | 2.18376551 |
| 87 | Dehydration (HP:0001944) | 2.16721310 |
| 88 | Protrusio acetabuli (HP:0003179) | 2.16555267 |
| 89 | Hypobetalipoproteinemia (HP:0003563) | 2.13893917 |
| 90 | Thin bony cortex (HP:0002753) | 2.12054975 |
| 91 | Poikiloderma (HP:0001029) | 2.08253874 |
| 92 | Abnormality of the renal medulla (HP:0100957) | 2.06061153 |
| 93 | Lymphangioma (HP:0100764) | 2.05523376 |
| 94 | Truncus arteriosus (HP:0001660) | 2.03821363 |
| 95 | Increased corneal curvature (HP:0100692) | 2.03368612 |
| 96 | Keratoconus (HP:0000563) | 2.03368612 |
| 97 | Nephronophthisis (HP:0000090) | 2.02641503 |
| 98 | Abnormality of Sharpey fibers (HP:0100685) | 2.02024828 |
| 99 | Vaginal fistula (HP:0004320) | 2.01060675 |
| 100 | Hyperglycemia (HP:0003074) | 1.99872892 |
| 101 | Breast hypoplasia (HP:0003187) | 1.97671500 |
| 102 | Widely patent fontanelles and sutures (HP:0004492) | 1.97579511 |
| 103 | Hyperthyroidism (HP:0000836) | 1.96973345 |
| 104 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.96778638 |
| 105 | Enlarged kidneys (HP:0000105) | 1.95677601 |
| 106 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.94878226 |
| 107 | Dicarboxylic aciduria (HP:0003215) | 1.92503252 |
| 108 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.92503252 |
| 109 | Potter facies (HP:0002009) | 1.92476880 |
| 110 | Facial shape deformation (HP:0011334) | 1.92476880 |
| 111 | Pancreatic fibrosis (HP:0100732) | 1.92398264 |
| 112 | Abnormality of DNA repair (HP:0003254) | 1.91693434 |
| 113 | Rectal prolapse (HP:0002035) | 1.90960348 |
| 114 | Abnormality of alanine metabolism (HP:0010916) | 1.90809270 |
| 115 | Hyperalaninemia (HP:0003348) | 1.90809270 |
| 116 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.90809270 |
| 117 | Glomerulosclerosis (HP:0000096) | 1.89149775 |
| 118 | Chronic hepatic failure (HP:0100626) | 1.87768902 |
| 119 | Rickets (HP:0002748) | 1.86759756 |
| 120 | Tubular atrophy (HP:0000092) | 1.86662661 |
| 121 | Vascular calcification (HP:0004934) | 1.85826464 |
| 122 | Duplicated collecting system (HP:0000081) | 1.83971145 |
| 123 | J-shaped sella turcica (HP:0002680) | 1.83751571 |
| 124 | Chorioretinal atrophy (HP:0000533) | 1.83694354 |
| 125 | Generalized muscle weakness (HP:0003324) | 1.81596698 |
| 126 | Tachypnea (HP:0002789) | 1.81100497 |
| 127 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.79428248 |
| 128 | Metabolic acidosis (HP:0001942) | 1.79408223 |
| 129 | Vomiting (HP:0002013) | 1.79004868 |
| 130 | Increased number of teeth (HP:0011069) | 1.78686364 |
| 131 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.78463677 |
| 132 | Cerebellar dysplasia (HP:0007033) | 1.78297681 |
| 133 | Delayed CNS myelination (HP:0002188) | 1.78078887 |
| 134 | Abnormality of the aortic arch (HP:0012303) | 1.77927418 |
| 135 | Protuberant abdomen (HP:0001538) | 1.77636251 |
| 136 | Unilateral renal agenesis (HP:0000122) | 1.77581820 |
| 137 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.76096070 |
| 138 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.76096070 |
| 139 | Premature rupture of membranes (HP:0001788) | 1.76040175 |
| 140 | True hermaphroditism (HP:0010459) | 1.75423583 |
| 141 | Tubulointerstitial fibrosis (HP:0005576) | 1.73397114 |
| 142 | Broad alveolar ridges (HP:0000187) | 1.73078643 |
| 143 | Hyperglycinemia (HP:0002154) | 1.72459574 |
| 144 | Hypoplasia of the pons (HP:0012110) | 1.72235837 |
| 145 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.71723112 |
| 146 | Absent epiphyses (HP:0010577) | 1.71723112 |
| 147 | Dysostosis multiplex (HP:0000943) | 1.71085295 |
| 148 | Pigmentary retinal degeneration (HP:0001146) | 1.71078637 |
| 149 | Abnormality of renal resorption (HP:0011038) | 1.69594692 |
| 150 | Abnormality of the pons (HP:0007361) | 1.67334869 |
| 151 | Enlarged epiphyses (HP:0010580) | 1.67153266 |
| 152 | Cardiovascular calcification (HP:0011915) | 1.67012953 |
| 153 | Bulbous nose (HP:0000414) | 1.66745903 |
| 154 | Hyperphosphatemia (HP:0002905) | 1.65927549 |
| 155 | Squamous cell carcinoma (HP:0002860) | 1.65738680 |
| 156 | Arthropathy (HP:0003040) | 1.64441993 |
| 157 | Intestinal fistula (HP:0100819) | 1.63751794 |
| 158 | Occipital encephalocele (HP:0002085) | 1.63690976 |
| 159 | Hyperammonemia (HP:0001987) | 1.63490084 |
| 160 | Microretrognathia (HP:0000308) | 1.63488199 |
| 161 | Bicornuate uterus (HP:0000813) | 1.63039370 |
| 162 | Hand muscle atrophy (HP:0009130) | 1.62927838 |
| 163 | Rectal fistula (HP:0100590) | 1.62811544 |
| 164 | Rectovaginal fistula (HP:0000143) | 1.62811544 |
| 165 | Abnormality of the wing of the ilium (HP:0011867) | 1.62723715 |
| 166 | Bronchomalacia (HP:0002780) | 1.60240087 |
| 167 | Mucopolysacchariduria (HP:0008155) | 1.59598371 |
| 168 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.59598371 |
| 169 | Hyperparathyroidism (HP:0000843) | 1.59563227 |
| 170 | Bowed forearm bones (HP:0003956) | 1.58872403 |
| 171 | Bowing of the arm (HP:0006488) | 1.58872403 |
| 172 | Slender long bone (HP:0003100) | 1.58840984 |
| 173 | Abnormality of carpal bone ossification (HP:0006257) | 1.57797810 |
| 174 | Large for gestational age (HP:0001520) | 1.57679399 |
| 175 | Abnormality of dentin (HP:0010299) | 1.57121512 |
| 176 | Facial hemangioma (HP:0000329) | 1.57118545 |
| 177 | Decreased central vision (HP:0007663) | 1.56643500 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK3 | 8.38392683 |
| 2 | * WNK4 | 6.33287789 |
| 3 | OXSR1 | 5.74673303 |
| 4 | STK39 | 3.96033746 |
| 5 | MAP2K6 | 2.76860237 |
| 6 | BMPR1B | 2.52284725 |
| 7 | INSRR | 2.48972379 |
| 8 | MAPK15 | 2.47420710 |
| 9 | ADRBK2 | 2.46752128 |
| 10 | ACVR1B | 2.37038783 |
| 11 | BCKDK | 2.36828093 |
| 12 | TLK1 | 2.31141026 |
| 13 | NEK2 | 2.30734437 |
| 14 | NME1 | 2.22506822 |
| 15 | TRIB3 | 2.07579838 |
| 16 | AKT3 | 2.05040474 |
| 17 | ZAK | 1.98624456 |
| 18 | PIK3CA | 1.97292698 |
| 19 | EEF2K | 1.94093702 |
| 20 | STK38L | 1.91127714 |
| 21 | MAPKAPK3 | 1.85530471 |
| 22 | ERN1 | 1.81150868 |
| 23 | TYRO3 | 1.71269448 |
| 24 | GRK1 | 1.64672180 |
| 25 | PDK3 | 1.55870224 |
| 26 | PDK4 | 1.55870224 |
| 27 | PRKD3 | 1.47262638 |
| 28 | SIK2 | 1.46587487 |
| 29 | NTRK3 | 1.44305534 |
| 30 | MAP4K2 | 1.42795009 |
| 31 | FRK | 1.42605735 |
| 32 | MST1R | 1.39667033 |
| 33 | MAPKAPK5 | 1.38709196 |
| 34 | SGK494 | 1.35610270 |
| 35 | SGK223 | 1.35610270 |
| 36 | MAP3K2 | 1.35387177 |
| 37 | PAK3 | 1.22138189 |
| 38 | PTK6 | 1.20462939 |
| 39 | PASK | 1.17423957 |
| 40 | PTK2 | 1.17215238 |
| 41 | PNCK | 1.16008195 |
| 42 | LATS1 | 1.13678881 |
| 43 | DAPK2 | 1.10836613 |
| 44 | DYRK1B | 1.10585194 |
| 45 | PIK3CG | 1.06595535 |
| 46 | EPHB1 | 1.03901561 |
| 47 | NEK1 | 1.03290095 |
| 48 | TRPM7 | 1.00916483 |
| 49 | SGK2 | 0.96548131 |
| 50 | SGK3 | 0.96546979 |
| 51 | PDGFRA | 0.96375626 |
| 52 | FGFR4 | 0.96089666 |
| 53 | ADRBK1 | 0.94604896 |
| 54 | FER | 0.93464817 |
| 55 | LMTK2 | 0.93346654 |
| 56 | PDK2 | 0.93319630 |
| 57 | PKN2 | 0.92985751 |
| 58 | BRSK2 | 0.92135329 |
| 59 | STK38 | 0.91549586 |
| 60 | FGFR3 | 0.88007045 |
| 61 | TIE1 | 0.86979973 |
| 62 | RIPK1 | 0.85901522 |
| 63 | MET | 0.84743396 |
| 64 | TTN | 0.84123956 |
| 65 | MAP3K3 | 0.82308114 |
| 66 | WEE1 | 0.80570636 |
| 67 | FGFR2 | 0.79549199 |
| 68 | PRKD2 | 0.78490087 |
| 69 | MUSK | 0.77088038 |
| 70 | EPHB2 | 0.76654807 |
| 71 | TGFBR1 | 0.73047839 |
| 72 | PRKAA1 | 0.73006222 |
| 73 | SIK1 | 0.72013620 |
| 74 | TAOK3 | 0.71613414 |
| 75 | MYLK | 0.71155543 |
| 76 | LRRK2 | 0.70813704 |
| 77 | FGFR1 | 0.69945688 |
| 78 | GSK3A | 0.69598787 |
| 79 | MAP2K2 | 0.69281219 |
| 80 | MAP3K1 | 0.68684352 |
| 81 | CDC42BPA | 0.68119134 |
| 82 | EPHA2 | 0.66338093 |
| 83 | HIPK2 | 0.65988743 |
| 84 | TGFBR2 | 0.62607408 |
| 85 | MAPK13 | 0.60526327 |
| 86 | CDK12 | 0.58018822 |
| 87 | PRKCI | 0.57093686 |
| 88 | CASK | 0.56437965 |
| 89 | NTRK1 | 0.56087896 |
| 90 | PAK4 | 0.55877122 |
| 91 | PRKCH | 0.55604544 |
| 92 | MTOR | 0.55290606 |
| 93 | IRAK3 | 0.52967733 |
| 94 | EIF2AK1 | 0.52552254 |
| 95 | MAP3K7 | 0.51071965 |
| 96 | RPS6KA2 | 0.48813455 |
| 97 | CSNK1E | 0.47558711 |
| 98 | EPHA3 | 0.43035931 |
| 99 | KSR2 | 0.43029342 |
| 100 | TTK | 0.42629804 |
| 101 | PRKD1 | 0.42585884 |
| 102 | BMX | 0.41492703 |
| 103 | UHMK1 | 0.41020954 |
| 104 | CHEK2 | 0.40864546 |
| 105 | CAMKK2 | 0.40807003 |
| 106 | PRKCG | 0.40558889 |
| 107 | PDPK1 | 0.39517483 |
| 108 | CAMK1G | 0.38904910 |
| 109 | PRKAA2 | 0.38373779 |
| 110 | CDK8 | 0.36571002 |
| 111 | DDR2 | 0.35501949 |
| 112 | BRSK1 | 0.35188702 |
| 113 | MAPK8 | 0.34781973 |
| 114 | RPS6KA6 | 0.34640440 |
| 115 | TAOK1 | 0.34480585 |
| 116 | FLT3 | 0.33515688 |
| 117 | PRKG2 | 0.32560529 |
| 118 | RET | 0.32445546 |
| 119 | MAP2K1 | 0.31451166 |
| 120 | AKT1 | 0.30375980 |
| 121 | CAMK1 | 0.29322712 |
| 122 | CDK1 | 0.28650117 |
| 123 | ICK | 0.28329603 |
| 124 | * SGK1 | 0.28261640 |
| 125 | PRKACG | 0.26911908 |
| 126 | PINK1 | 0.25839254 |
| 127 | TESK1 | 0.25444298 |
| 128 | ROCK1 | 0.24568321 |
| 129 | PTK2B | 0.23138051 |
| 130 | CAMK1D | 0.23017150 |
| 131 | MAPK11 | 0.22627561 |
| 132 | ERBB2 | 0.22093024 |
| 133 | DMPK | 0.19068476 |
| 134 | PHKG2 | 0.18757364 |
| 135 | PHKG1 | 0.18757364 |
| 136 | MARK2 | 0.17409029 |
| 137 | PDGFRB | 0.17392376 |
| 138 | MAP3K10 | 0.16966337 |
| 139 | PRKACA | 0.16265899 |
| 140 | JAK2 | 0.15761680 |
| 141 | CAMK2D | 0.15590857 |
| 142 | PRKCE | 0.15551850 |
| 143 | MST4 | 0.15070356 |
| 144 | PRKCZ | 0.13834563 |
| 145 | PAK2 | 0.13184740 |
| 146 | CSNK1A1 | 0.11630345 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.91961017 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.29261309 |
| 3 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.05202620 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.98786039 |
| 5 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.92390699 |
| 6 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.83461356 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.70760443 |
| 8 | Sulfur relay system_Homo sapiens_hsa04122 | 2.65139284 |
| 9 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.61008061 |
| 10 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.59292748 |
| 11 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.53249332 |
| 12 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.51415144 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.39697372 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.36789966 |
| 15 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.29454397 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.10868718 |
| 17 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.95361510 |
| 18 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.93256563 |
| 19 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.93092712 |
| 20 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.92725712 |
| 21 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.85400752 |
| 22 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.83410248 |
| 23 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.82293840 |
| 24 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.80771509 |
| 25 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.80335718 |
| 26 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.79122862 |
| 27 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.74646152 |
| 28 | Peroxisome_Homo sapiens_hsa04146 | 1.71278819 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.65283520 |
| 30 | Lysine degradation_Homo sapiens_hsa00310 | 1.63928521 |
| 31 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.58514399 |
| 32 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.51837191 |
| 33 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.50260328 |
| 34 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.50054340 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.46591272 |
| 36 | Carbon metabolism_Homo sapiens_hsa01200 | 1.44760296 |
| 37 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.44711832 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.37698458 |
| 39 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.36290364 |
| 40 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.35937277 |
| 41 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.32044931 |
| 42 | Other glycan degradation_Homo sapiens_hsa00511 | 1.31146143 |
| 43 | Mineral absorption_Homo sapiens_hsa04978 | 1.27786285 |
| 44 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.26146012 |
| 45 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.20852148 |
| 46 | Insulin secretion_Homo sapiens_hsa04911 | 1.20482745 |
| 47 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.19494627 |
| 48 | Phototransduction_Homo sapiens_hsa04744 | 1.17523590 |
| 49 | Retinol metabolism_Homo sapiens_hsa00830 | 1.16561558 |
| 50 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.15655975 |
| 51 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.14860153 |
| 52 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.11410572 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.10723927 |
| 54 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.06125812 |
| 55 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.04196087 |
| 56 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.02593781 |
| 57 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.02135598 |
| 58 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.98979199 |
| 59 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.98046330 |
| 60 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.96797892 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.94979674 |
| 62 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.94885632 |
| 63 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.94684922 |
| 64 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.93861269 |
| 65 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.92870811 |
| 66 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.90335442 |
| 67 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.90188866 |
| 68 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.89867536 |
| 69 | Protein export_Homo sapiens_hsa03060 | 0.89341055 |
| 70 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.88967326 |
| 71 | Homologous recombination_Homo sapiens_hsa03440 | 0.86715806 |
| 72 | Lysosome_Homo sapiens_hsa04142 | 0.85902347 |
| 73 | Basal transcription factors_Homo sapiens_hsa03022 | 0.85388631 |
| 74 | Taste transduction_Homo sapiens_hsa04742 | 0.83956406 |
| 75 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.77809544 |
| 76 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.77129263 |
| 77 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.76671840 |
| 78 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.76268728 |
| 79 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.75516040 |
| 80 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.74846875 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.74476706 |
| 82 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.72073564 |
| 83 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.71772935 |
| 84 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.69968983 |
| 85 | Histidine metabolism_Homo sapiens_hsa00340 | 0.69442514 |
| 86 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.68597514 |
| 87 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.67643221 |
| 88 | Bladder cancer_Homo sapiens_hsa05219 | 0.67513067 |
| 89 | ABC transporters_Homo sapiens_hsa02010 | 0.66074613 |
| 90 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.64306290 |
| 91 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.63934500 |
| 92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.63667516 |
| 93 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60208536 |
| 94 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.59366891 |
| 95 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.55576271 |
| 96 | RNA polymerase_Homo sapiens_hsa03020 | 0.54799393 |
| 97 | Parkinsons disease_Homo sapiens_hsa05012 | 0.54070931 |
| 98 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.52915417 |
| 99 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.52526504 |
| 100 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.50071286 |
| 101 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.48004934 |
| 102 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.46019646 |
| 103 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.44409870 |
| 104 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.42010832 |
| 105 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.41759507 |
| 106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41195505 |
| 107 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.41125194 |
| 108 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.39608097 |
| 109 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.39125429 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38577028 |
| 111 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.37157530 |
| 112 | Nicotine addiction_Homo sapiens_hsa05033 | 0.36951698 |
| 113 | Tight junction_Homo sapiens_hsa04530 | 0.36607264 |
| 114 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36009748 |
| 115 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35672644 |
| 116 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.35108065 |
| 117 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.33629024 |
| 118 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.33626401 |
| 119 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.33509753 |
| 120 | Galactose metabolism_Homo sapiens_hsa00052 | 0.33148965 |
| 121 | Cocaine addiction_Homo sapiens_hsa05030 | 0.32877680 |
| 122 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.32506155 |
| 123 | Alzheimers disease_Homo sapiens_hsa05010 | 0.32268136 |
| 124 | Focal adhesion_Homo sapiens_hsa04510 | 0.32080844 |
| 125 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.31952868 |
| 126 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.31383747 |
| 127 | Circadian rhythm_Homo sapiens_hsa04710 | 0.29914882 |
| 128 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.26267822 |
| 129 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.25602512 |
| 130 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.25380805 |
| 131 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.23737614 |
| 132 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.22951799 |
| 133 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.22833654 |
| 134 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22274078 |
| 135 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.21149513 |
| 136 | Adherens junction_Homo sapiens_hsa04520 | 0.21024018 |
| 137 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.21007074 |
| 138 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.18398482 |

